|
In Case
You Missed It!
View the Slides
I
Listen to the Audio
Summary: This
webinar presented on June 8, 2011, covered how PST first began in
Germany, and the US launch in 1997. Then it will move
into present day with a review of the challenges of
managing warfarin patients, the demographics driving the
need for better management, and a discussion of the peer
reviewed literature supporting PST as an adjunct to
traditional management. This will be followed by the
practical aspects of PST which includes patient
selection and training, communication between
practitioners and patients, current reimbursement, and
accuracy of INR devices. The presentation will conclude
with a summary of the group of new drugs described as
oral fixed dose anticoagulants (i.e. factor Xa
inhibitors and direct thrombin inhibitors) that do not
require monitoring and the potential impact on warfarin
Objectives:
After this webinar, you will be able to:
-
Review the need for better anticoagulation
management
-
Be supplied with the clinical underpinnings that
support the adoption of PST for properly selected
and suitable trained patients
-
Understand the issues needed to be addressed to
successfully implement a PST program within a
practice
-
Receive a summary of the new non-monitored drugs and
how this new class of anticoagulants will impact the
traditional management of warfarin patients
Vendor Sponsors:
-
Alere
-
Eurotrol
-
Medical Automation Systems
-
Radiometer
-
Siemens
 About
the Presenter:
David Phillips brings over 30 years of experience in the
in-vitro diagnostics industry with the last 20 years in
the point-of-care segment. He has specific experience in
POC coagulation for the physician office, acute care
markets and patient self-testing (PST). He is currently
VP, Market Development at Alere. Prior to joining Alere,
he was Marketing Director for Abbott Point of Care, i-STAT
Division. From 1990 to 2001, he was Director of
Marketing in the Point of Care business unit for Roche
Diagnostics. During his tenure at Roche he launched the
CoaguChek for patient self-testing and was instrumental
in developing strategies for reimbursement and
regulatory issues affecting POCT. Additional industry
activities include serving as Chairman of the CLSI
Quality Management for Unit-use Testing Subcommittee
(EP-18A), member of the CLSI Point-of-Care Testing and
Point-of-Care Coagulation Subcommittees and an advisor
to the CLSI Area Committee on POC. He has also served
as the AdvaMed industry liaison to the College of
American Pathologists (CAP) POCT Subcommittee.
Over the last
decade, his articles on point-of-care testing have
appeared in such publications as Archives Pathology and
Laboratory Medicine, Clinica Chimica Acta, Clinical
Chemistry, and Clinical Chemistry News and most recently
a book chapter on “Unit Use Quality Control” published
in Point of Care Testing, Second Edition by the AACC
Press. |
